Ameritas Investment Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.4K | Buy |
+7,081
| New | +$45.4K | ﹤0.01% | 2244 |
|
|
2024
Q2 | – | Sell |
-5,046
| Closed | -$14.3K | – | 3125 |
|
|
2024
Q1 | $14.3K | Hold |
5,046
| – | – | ﹤0.01% | 2697 |
|
|
2023
Q4 | $74.3K | Hold |
5,046
| – | – | ﹤0.01% | 1925 |
|
|
2023
Q3 | $92.4K | Buy |
5,046
+1,011
| +25% | +$18.5K | ﹤0.01% | 1717 |
|
|
2023
Q2 | $87K | Hold |
4,035
| – | – | ﹤0.01% | 1692 |
|
|
2023
Q1 | $118K | Hold |
4,035
| – | – | ﹤0.01% | 1436 |
|
|
2022
Q4 | $153K | Buy |
4,035
+1,271
| +46% | +$48.2K | 0.01% | 1315 |
|
|
2022
Q3 | $77K | Buy |
2,764
+2,020
| +272% | +$56.3K | ﹤0.01% | 1678 |
|
|
2022
Q2 | $14K | Hold |
744
| – | – | ﹤0.01% | 2708 |
|
|
2022
Q1 | $10K | Buy |
+744
| New | +$10K | ﹤0.01% | 2788 |
|